Marshall Wace North America’s Innospec IOSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-15,789
Closed -$1.22M – 1335
2020
Q2
$1.22M Buy
15,789
+4,357
+38% +$319K 0.01% 709
2020
Q1
$795K Buy
11,432
+10,727
+1,522% +$980K 0.01% 654
2019
Q4
$73K Sell
705
-112
-14% -$10.7K ﹤0.01% 1095
2019
Q3
$73K Buy
+817
New +$73.2K ﹤0.01% 1106
2019
Q1
– Sell
-671
Closed -$41K – 1718
2018
Q4
$41K Sell
671
-31,209
-98% -$2.15M ﹤0.01% 1301
2018
Q3
$2.45M Buy
31,880
+29,117
+1,054% +$2.27M 0.02% 453
2018
Q2
$212K Buy
+2,763
New +$207K ﹤0.01% 1262
2017
Q4
– Sell
-19,596
Closed -$1.22M – 1476
2017
Q3
$1.22M Buy
+19,596
New +$1.17M 0.01% 909
2017
Q2
– Sell
-11,213
Closed -$729K – 1367
2017
Q1
$729K Buy
+11,213
New +$750K 0.01% 752

Other funds holding IOSP

Marshall Wace North America's IOSP Position: Q3 2020 in Review

Marshall Wace North America sold out of Innospec (IOSP) in Q3 2020, closing a stake of 15,789 shares — an estimated $1.22M sold.

Marshall Wace North America first reported a position in IOSP in Q1 2017 and held it in 9 quarters. The position peaked at $2.45M in Q3 2018. 189 funds tracked by Wall St. Rank hold IOSP as of Q3 2020.

  • Marshall Wace North America reported no remaining Innospec position as of Q3 2020 after selling out during the quarter.
  • Marshall Wace North America sold 15,789 Innospec shares in Q3 2020, an estimated $1.22M.
  • Marshall Wace North America first reported a position in Innospec in Q1 2017 and held it in 9 quarters.
  • Marshall Wace North America's Innospec position peaked at $2.45M in Q3 2018.
  • 189 funds tracked by Wall St. Rank held Innospec as of Q3 2020.

Based on Marshall Wace North America's 13F filing for Q3 2020, filed 16 Nov 2020.